Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 25, 2024
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
[ Wed, Sep 25th 2024
] - WOPRAI
Tue, September 24, 2024
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
Joseph Pantginis Reiterated (CAPR) at Strong Buy and Held Target at $40 on, Sep 24th, 2024
Joseph Pantginis of HC Wainwright & Co., Reiterated "Capricor Therapeutics, Inc." (CAPR) at Strong Buy and Held Target at $40 on, Sep 24th, 2024.
Joseph has made no other calls on CAPR in the last 4 months.
There are 3 other peers that have a rating on CAPR. Out of the 3 peers that are also analyzing CAPR, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Joseph
- Leland Gershell of "Oppenheimer" Reiterated at Buy and Held Target at $15 on, Monday, September 23rd, 2024
- Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $8 on, Friday, September 20th, 2024
- Jason McCarthy of "Maxim Group" Reiterated at Strong Buy and Held Target at $12 on, Tuesday, September 17th, 2024
